REDW Wealth’s AbbVie ABBV Stock Holding History

REDW Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$287K	Sell	1,318 -3	-0.2%	-$665	0.11%	88
2025 Q4	$302K	Buy	1,321 +20	+2%	+$4.56K	0.12%	86
2025 Q3	$301K	Sell	1,301 -25	-2%	-$5.09K	0.11%	90
2025 Q2	$246K	Buy	1,326 +27	+2%	+$5.02K	0.1%	95
2025 Q1	$272K	Buy	1,299 +72	+6%	+$14K	0.1%	86
2024 Q4	$218K	Sell	1,227 -375	-23%	-$68.9K	0.08%	97
2024 Q3	$316K	Hold	1,602	–	–	0.08%	123
2024 Q2	$275K	Hold	1,602	–	–	0.07%	130
2024 Q1	$292K	Hold	1,602	–	–	0.08%	126
2023 Q4	$248K	Buy	1,602 +138	+9%	+$20.1K	0.07%	130
2023 Q3	$218K	Buy	+1,464	New	+$215K	0.07%	131
2023 Q2	–	Sell	-1,380	Closed	-$220K	–	143
2023 Q1	$220K	Buy	1,380 +66	+5%	+$10.1K	0.07%	134
2022 Q4	$212K	Buy	+1,314	New	+$201K	0.07%	126
2022 Q3	–	Sell	-1,449	Closed	-$222K	–	111
2022 Q2	$222K	Hold	1,449	–	–	0.08%	107
2022 Q1	$235K	Buy	+1,449	New	+$210K	0.07%	112
2018 Q1	–	Sell	-2,108	Closed	-$204K	–	83
2017 Q4	$204K	Buy	+2,108	New	+$199K	0.16%	80

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

REDW Wealth's ABBV Position: Q1 2026 in Review

REDW Wealth reduced its AbbVie (ABBV) stake by 0.23% in Q1 2026, selling an estimated $665 and leaving 1,318 shares worth $287K. The position accounts for 0.11% of the portfolio, ranked #88.

REDW Wealth first reported a position in ABBV in Q4 2017 and has held it in 16 quarters since. The position peaked at $316K in Q3 2024. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

REDW Wealth held 1,318 shares of AbbVie worth $287K as of Q1 2026.
REDW Wealth sold 3 AbbVie shares in Q1 2026, an estimated $665.
AbbVie made up 0.11% of REDW Wealth's portfolio in Q1 2026, its #88 holding.
REDW Wealth first reported a position in AbbVie in Q4 2017 and has held it in 16 quarters since.
REDW Wealth's AbbVie position peaked at $316K in Q3 2024.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on REDW Wealth's 13F filing for Q1 2026, filed 8 May 2026.